九安医疗变更回购股份用途并注销，拟减少注册资本

Group 1 - The company held its 25th meeting of the 6th Board of Directors and the 20th meeting of the 6th Supervisory Board on September 5, 2025, where it approved a proposal to change the purpose of part of the repurchased shares and to cancel them [1] - The company will change the purpose of 9,771,882 shares from "maintaining company value and shareholder rights through sale" to "cancellation and reduction of registered capital," while the remaining purposes will remain unchanged [1] - This matter was approved and became effective at the third extraordinary general meeting of shareholders held on September 22, 2025 [1] Group 2 - Creditors are required to declare their claims within 30 days of receiving the notification or within 45 days from the date of announcement if they did not receive a notification [2] - Required materials for claim declaration include original and photocopies of contracts or agreements proving the creditor-debtor relationship, along with identification documents for legal and natural persons [2] - The declaration period is from September 23, 2025, to November 6, 2025, during specified working hours, and the declaration can be submitted in person or by mail [2] Group 3 - The company issued its first phase of technology innovation bonds for 2025 on August 21, 2025, and the cancellation of repurchased shares and reduction of registered capital does not trigger the need to convene a bondholders' meeting [3]